Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 10/20 | 0.41 |
| ▸ | NPY1R | P25929 | 6/20 | 0.41 |
| ▸ | NPY2R | P49146 | 4/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.38 |
| ▸ | OTC | P00480 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 2/20 | 0.34 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.34 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7782784 | 1.00 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL5635045 | 0.91 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL17371757 | 0.89 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL23408857 | 0.87 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL6155572 | 0.87 | NPY4R (0.39) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL15459530 | 0.87 | NPY4R (0.39) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL42488 | 0.85 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL2172217 | 0.85 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL157856 | 0.85 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL8627066 | 0.84 | NPY4R (0.36) | NPY4RNPY1RNPY2RNPY5RDPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018044840-A1 | SYNERGISTIC CATIONIC SURFACTANTS RESULTING IN MICROBIAL INHIBITION ON FOOD SURFACES AND HARD SURFACES | CRYOVAC, INC. (US) | 2018-03-08 | — | — | WO | claimed |
| WO-2018044840-A1 | SYNERGISTIC CATIONIC SURFACTANTS RESULTING IN MICROBIAL INHIBITION ON FOOD SURFACES AND HARD SURFACES | CRYOVAC, INC. (US) | 2018-03-08 | — | — | WO | disclosed |
| US-20160030318-A1 | HIGHLY BIOAVAILABLE Na-ACYL ACIDIC AMINO ACID ESTER SALT COMPOSITONS WITH ZWITTERIONIC SURFACTANTS | JOHNSON & JOHNSON CONSUMER INC. | 2016-02-04 | — | — | US | disclosed |
| US-20160030317-A1 | HIGHLY BIOAVAILABLE Na-ACYL ACIDIC AMINO ACID ESTER SALT COMPOSITONS WITH ZWITTERIONIC SURFACTANTS | JOHNSON & JOHNSON CONSUMER INC. | 2016-02-04 | — | — | US | disclosed |
| CN-101415641-B | Modified clay mineral | AJINOMOTO CO.,INC. (JP) | 2012-02-08 | — | — | CN | disclosed |
| CN-101415641-A | Modified clay mineral | AJINOMOTO KK (JP) | 2009-04-22 | — | — | CN | disclosed |
| EP-1135398-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | Monsanto Technology LLC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6218563-B1 | Cyanophosphonamides and method for preparation | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| WO-2000032611-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | MONSANTO TECHNOLOGY LLC (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-1999029289-A1 | STABILIZED ORAL COMPOSITIONS CONTAINING (N ALPHA-ACYL-L-ARGININE) ALKYL ESTER SALTS | WARNER-LAMBERT COMPANY (US) | 1999-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160030318-A1 | HIGHLY BIOAVAILABLE Na-ACYL ACIDIC AMINO ACID ESTER SALT COMPOSITONS WITH ZWITTERIONIC SURFACTANTS | SLC7A1, SLC6A15, SLC38A7 | NPY4R 1261/4885NPY1R 504/4885NPY2R 1103/4885 |
| US-20160030317-A1 | HIGHLY BIOAVAILABLE Na-ACYL ACIDIC AMINO ACID ESTER SALT COMPOSITONS WITH ZWITTERIONIC SURFACTANTS | SLC7A1, SLC6A15, SLC38A7 | NPY4R 1261/4885NPY1R 504/4885NPY2R 1103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.